about
Epidemiology of Carbapenem Resistant Klebsiella pneumoniae Infections in Mediterranean CountriesComparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusionCombination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data.Pulmonary infections complicating hematological disorders.Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.The role of antimicrobial policies in neutropenic patients.Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum.Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia.Scedosporiosis in patients with acute leukemia: a retrospective multicenter report.Galactomannan detection in Geotrichum capitatum invasive infections: report of 2 new cases and review of diagnostic options.Safety and interactions of new antifungals in stem cell transplant recipients.Strongyloides stercoralis infection in allogeneic stem cell transplant: a case report and review of the literature.Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation.Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper.Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.An update on the safety and interactions of antifungal drugs in stem cell transplant recipients.Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.The predictive value of Aspergillus PCR testing on bronchoalveolar lavage fluid for early diagnosis of invasive pulmonary aspergillosis in hematologic patients.Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimen.Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres.Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.Pulmonary fungal infections in patients with acute myeloid leukaemia: is it the time to revise the radiological diagnostic criteria?The diagnostic role of galactomannan during antifungal prophylaxis. Comment on: "The role of antifungal treatment in hematology". Haematologica 2012;97(3):325-7.Are we making progress in antifungal therapy?Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy.The Start-Up of the first Hematopoietic Stem Cell Transplantation Center in the Iraqi Kurdistan: a Capacity-Building Cooperative Project by the Hiwa Cancer Hospital, Sulaymaniyah, and the Italian Agency for Development Cooperation: an Innovative AppIncidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis.Contamination by cardboard particles as a cause of false-positive results for Aspergillus galactomannan enzyme immunoassaysProphylaxis of invasive fungal diseases in patients with hematologic disordersCombined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies.Late listeriosis after fludarabine plus prednisone treatment.Cross-recognition of aspergillus galactomannan caused by Listeria monocytogenes infection.Detection of cytomegalovirus late (pp150) antigen in peripheral blood leukocytes of patients with human immunodeficiency virus-related lymphoma.Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology).Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres.Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GTrigeminal neuralgia as unusual isolated symptom of fungal paranasal sinusitis in patients with haematological malignancies.
P50
Q26738606-D491C59A-DBAC-4442-B086-CAC7C9010703Q30311996-397612DE-C92A-47EA-BE6D-75D632DDA238Q30873926-15427184-EB03-4635-868E-E9AF7FA00297Q33369131-005CB01E-EFA5-4C93-92EC-CB36F27F5814Q34007574-ABED67D9-1914-426F-97FB-C468ABDCF7EFQ34088946-799B2F3A-DF2F-4CB5-A64B-83B059054AF7Q35073287-3B051294-FB5E-40C6-B400-0F5DCC7B1075Q37026715-7C27EC33-881C-420E-B87C-6B192B772EDDQ37048143-54E34402-6EE1-4F5E-80D6-889624A6B57AQ37306205-55C961DD-6816-4F2B-A9D8-849EDB04D847Q38036740-6A0B8129-DEC2-4FFC-8747-9F65DC1B4B40Q38217076-A276EF74-5FCC-4D14-8B6A-DB80AC9A687AQ38258113-8BFA4010-8257-4D18-990D-CC89D07F73E0Q38664059-FF025D6F-1D13-463D-BD3A-EBA6B7F31D1FQ38797546-999FFA21-CCC1-4743-8E68-76232338AD9CQ39048531-215AF39C-7358-4A70-9FC1-FA456EDC8977Q39196802-21B41FC8-9E7C-4DC0-BACA-8466D2AB5D01Q40210434-7C90A90A-A320-48A6-B966-2AB59758D30FQ40558999-08A5E85D-FA91-4542-AB9E-BC7E81B6E827Q40583859-7B3D9C72-EC51-430D-B42F-A41F27C6E44EQ40723790-F3CDCEA7-D301-4138-9258-1C2DC7559B10Q40796360-1B60BDAA-5D60-4F8C-8467-C34C74C77DD3Q41538982-50CD66DA-A9B0-4BDF-AC72-40D697722356Q41558255-C2A4146B-F6A0-4673-B84D-F79222C345CEQ41703672-464988DC-95FD-4F87-97C9-78099437BD46Q42119640-B685DD94-4FAA-4838-A550-7B18FFC8D7C8Q42223864-DE856678-A9B0-4250-80FD-DE5822A4DBB3Q42257843-106E7FCB-1E8F-4130-B56A-3350C28090AFQ42413223-DADF0B54-E69C-48CB-BD64-ADB02A2D7972Q42415929-15F55AD9-5EC4-4B8F-A75E-08F76B76A0DEQ42958723-52784984-53CA-400A-A8A6-862DEAB740C1Q44146174-832E7D27-89DD-4EC1-99F5-A87440A8F714Q44735422-CD9F6E5A-DA03-44A9-8770-8548998E376FQ45362568-66CFF27A-2988-4A60-8E6B-FBDC3AAA007CQ45741665-C6CF7219-EF46-4D72-BA21-87F51F95DC55Q45945768-E00B9B14-0195-40E0-A159-763AC866D462Q46480343-D60896BD-D569-4689-84E6-B4F0DE71FF5EQ49385523-51358ABB-38F5-451B-BA45-D614EF51C7BCQ52725123-2E2FDA1D-2332-48E7-850F-FACDADF16011Q53198358-146EEDB7-CB89-49B3-986D-652470358227
P50
description
researcher
@en
wetenschapper
@nl
name
C Girmenia
@en
C Girmenia
@nl
type
label
C Girmenia
@en
C Girmenia
@nl
prefLabel
C Girmenia
@en
C Girmenia
@nl
P106
P31
P496
0000-0002-3245-2357